Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
St. Joseph's Medicine Co. is a historic pharmaceutical entity primarily recognized for the development and commercialization of the St. Joseph brand of aspirin. Originally established in the late 19th century and later expanded by Abe Plough of Plough, Inc., the company became a leader in the over-the-counter (OTC) market, particularly for pediatric and low-dose aspirin. The brand has transitioned through several major pharmaceutical owners, including Schering-Plough and Merck & Co., following various mergers and acquisitions. Currently, the assets of St. Joseph's Medicine Co. are owned by Foundation Consumer Healthcare, which focuses on the brand's legacy in cardiovascular health. The company's primary product remains its 81mg low-dose aspirin, widely used for the secondary prevention of heart attacks and strokes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on St. Joseph's Medicine Co..